GF
AUPH icon

Gabelli Funds’s Aurinia Pharmaceuticals AUPH Stock Holding History

Gabelli Funds’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-280,000
Closed -$2.11M – 1217
2022
Q3 		$2.11M Sell
280,000
-110,000
-28% -$952K 0.02% 640
2022
Q2 		$3.92M Hold
390,000
– – 0.03% 515
2022
Q1 		$4.83M Buy
390,000
+30,000
+8% +$464K 0.03% 515
2021
Q4 		$8.23M Buy
360,000
+45,000
+14% +$1.07M 0.05% 385
2021
Q3 		$6.97M Buy
315,000
+25,000
+9% +$397K 0.05% 425
2021
Q2 		$3.76M Buy
290,000
+55,000
+23% +$701K 0.02% 598
2021
Q1 		$3.05M Buy
+235,000
New +$3.41M 0.02% 634

Other funds holding AUPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Gabelli Funds's AUPH Position: Q4 2022 in Review

Gabelli Funds sold out of Aurinia Pharmaceuticals (AUPH) in Q4 2022, closing a stake of 280,000 shares — an estimated $2.11M sold.

Gabelli Funds first reported a position in AUPH in Q1 2021 and held it in 7 quarters. The position peaked at $8.23M in Q4 2021. 191 funds tracked by Wall St. Rank hold AUPH as of Q4 2022.

  • Gabelli Funds reported no remaining Aurinia Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Gabelli Funds sold 280,000 Aurinia Pharmaceuticals shares in Q4 2022, an estimated $2.11M.
  • Gabelli Funds first reported a position in Aurinia Pharmaceuticals in Q1 2021 and held it in 7 quarters.
  • Gabelli Funds's Aurinia Pharmaceuticals position peaked at $8.23M in Q4 2021.
  • 191 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q4 2022.

Based on Gabelli Funds's 13F filing for Q4 2022, filed 13 Feb 2023.